These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15230214)

  • 41. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA; Esquifino AI
    Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Hyperprolactinemia and Clinically Apparent Prolactinomas in Men Undergoing Fertility Evaluation.
    Ambulkar SS; Darves-Bornoz AL; Fantus RJ; Wren J; Bennett NE; Halpern JA; Brannigan RE
    Urology; 2022 Jan; 159():114-119. PubMed ID: 33766719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
    Shimon I; Hirsch D; Tsvetov G; Robenshtok E; Akirov A; Fraenkel M; Eizenberg Y; Herzberg D; Barzilay-Yoseph L; Livner A; Friedrich I; Manisterski Y; Ishay A; Yoel U; Masri H
    Endocrine; 2019 Sep; 65(3):656-661. PubMed ID: 31154607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased sensitivity to the negative feedback effects of testosterone induced by hyperprolactinemia in the adult male rat.
    McNeilly AS; Sharpe RM; Fraser HM
    Endocrinology; 1983 Jan; 112(1):22-8. PubMed ID: 6401176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
    Rubio MA; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1989 Aug; 69(2):444-7. PubMed ID: 2526819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [An endocrinological study of hyperprolactinemia and its treatment (author's transl)].
    Kimura T; Narita O; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):784-92. PubMed ID: 6787150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The importance of hyperprolactinemia in impotence.
    Netto Júnior NR; Claro Jde A
    Rev Paul Med; 1993; 111(6):454-5. PubMed ID: 8052792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unusual prolactin response to luteinizing hormone-releasing hormone in some anovulatory women.
    Giampietro O; Moggi G; Chisci R; Coluccia A; Luche AD; Simonini N; Brunori I
    J Clin Endocrinol Metab; 1979 Jul; 49(1):141-3. PubMed ID: 376544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hypothalamo-hypophyseo-gonadal axis in individuals with chronic renal insufficiency subjected to hemodialysis].
    Mendoza C; Carreras A; Ruiz E; Ortega E; Hervás J; Osorio C
    Rev Esp Fisiol; 1985 Dec; 41(4):443-6. PubMed ID: 3938041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperprolactinemia--a review of recent clinical advances.
    Kirby RW; Kotchen TA; Rees ED
    Arch Intern Med; 1979 Dec; 139(12):1415-9. PubMed ID: 518224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatment.
    Modebe O
    Int J Fertil Menopausal Stud; 1994; 39(2):95-9. PubMed ID: 8012447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of hypothyroidism in male infertility and erectile dysfunction.
    Nikoobakht MR; Aloosh M; Nikoobakht N; Mehrsay AR; Biniaz F; Karjalian MA
    Urol J; 2012; 9(1):405-9. PubMed ID: 22395839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
    Oseko F; Morikawa K; Motohashi T; Aso T
    Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum prolactin levels in male patients with erectile dysfunction.
    Rao K; Rao MS; Gupta AN; Sialy R; Vaidyanathan S
    Indian J Med Res; 1981 Sep; 74():412-4. PubMed ID: 6797939
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nocturnal increase of plasma testosterone in men: relation to gonadotropins and prolactin.
    Rubin RT; Gouin PR; Lubin A; Poland RE; Pirke KM
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1027-33. PubMed ID: 1133152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperprolactinemia and impotence.
    el-Beheiry A; Souka A; el-Kamshoushi A; Hussein S; el-Sabah K
    Arch Androl; 1988; 21(3):211-4. PubMed ID: 3245713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.